FDA does not sign off on a supplement before it goes on sale. That does not mean supplements are unregulated. It means the brand carries the burden, and FDA and Amazon check after the fact.
Short answer
No. FDA does not have the authority to approve dietary supplements for safety or effectiveness, or to approve their labels, before they are sold. Instead, the law requires facility registration, compliance with the cGMP rule in 21 CFR Part 111, a 75-day premarket notice for new dietary ingredients, serious adverse event reporting, and correct labeling. FDA enforces after products reach the market.
None
Supplements FDA approves for safety and effectiveness before sale; the law gives it no such authority
FDA 101: Dietary Supplements
75 days
Minimum notice to FDA before marketing a supplement with certain new dietary ingredients
21 CFR 190.6
15 business days
Deadline to send FDA a serious adverse event report after the brand receives it
21 U.S.C. 379aa-1
30 days
Window to notify FDA after first marketing a supplement with a structure/function claim
21 CFR 101.93(a)
FDA says it plainly in its consumer guide: the agency does not have the authority to approve dietary supplements for safety and effectiveness, or to approve their labeling, before they are sold to the public (FDA 101: Dietary Supplements). That framework comes from the Dietary Supplement Health and Education Act of 1994, usually called DSHEA, which amended the Federal Food, Drug, and Cosmetic Act (FD&C Act) and treats supplements as a kind of food rather than a drug.
So who checks a supplement before launch? The company does. FDA's questions and answers page says a firm is responsible for making sure the supplements it makes or distributes are not adulterated or misbranded, and generally does not have to show FDA its safety evidence before or after marketing. FDA's role mostly starts after the product is on the market, through inspections, label reviews, adverse event reports and enforcement.
That is the opposite of drugs. The same page notes that drugs must be proven safe and effective before marketing, while the law has no provision for FDA to approve supplements for safety before they reach consumers. It also says FDA does not test supplements before they are sold.
There is one narrow exception on claims. FDA's Q&A page notes that certain claims, such as health claims about reducing the risk of a disease, require premarket review and authorization. The product itself still is not approved. For how claims work day to day, see our structure/function claims guide.
No approval does not mean no rules. These six obligations apply to most supplement brands, either directly or through the manufacturer you hire. The table names the rule behind each one.
Advertising is a separate track. FDA's Q&A page says FDA is generally responsible for safety, quality and labeling, and the Federal Trade Commission (FTC) for advertising. The FTC's Health Products Compliance Guidance says health claims need competent and reliable scientific evidence, which for most health benefits means human clinical trials.
Under 21 CFR 1.231(c), no registration fee is required, and FDA says on its registration fees page that it does not issue or recognize certificates of registration. If someone sells you an "FDA certificate," it did not come from FDA. A registration number only means the facility is registered (21 CFR 1.242).
21 CFR Part 111 applies to anyone who manufactures, packages, labels or holds a dietary supplement (111.1). It requires specifications for each component and finished batch (111.70), at least one identity test on each dietary ingredient before use (111.75(a)(1)), batch records (111.255), and records kept for 1 year past the shelf life date or 2 years after the last batch ships (111.605). Products made outside these rules are adulterated under 21 U.S.C. 342(g).
A new dietary ingredient is one not marketed in the U.S. before October 15, 1994. If it has not been in the food supply in an unaltered form, the maker or distributor must give FDA its safety basis at least 75 days before marketing (21 CFR 190.6).
Under 190.6(f), FDA's failure to respond to a notice is not a finding that the ingredient is safe. FDA keeps the notice confidential for 90 days, then makes it public, except trade secrets (190.6(e)).
Under 21 U.S.C. 379aa-1, the manufacturer, packer or distributor named on the label is the responsible person. Serious events include death, a life-threatening experience, hospitalization, lasting disability or a birth defect. Reports go on the MedWatch form within 15 business days, and records are kept for 6 years. That is why the label must carry a domestic address or phone number for reports.
If you are a brand that hires a contract manufacturer, the facility handles its own registration and most production records. You still own the label, the claims, the adverse event reporting and, under Part 111, responsibility for what goes out under your name. Our guide to vetting a supplement manufacturer shows how to confirm a facility is doing its part, and our supplement label requirements page covers the label line by line.
Because there is no approval step, enforcement is where FDA does most of its work on supplements. The FDA 101 page lists the main tools: periodic facility inspections, reviews of labels and websites for disease claims, monitoring adverse event reports, and, when a product is unsafe or out of compliance, working with the company, asking for a voluntary recall, or acting to remove a dangerous product.
An FDA investigator inspects the facility. At the end of the inspection, the investigator hands over Form FDA 483, Inspectional Observations, and the company can answer in writing.
If the violations are significant, FDA sends a warning letter and posts it publicly. A January 2026 letter to a supplement maker cited missing finished-product specifications under 21 CFR 111.70(e), and called a capsule product misbranded because its serving size did not match its directions.
That letter asked the company to reply in writing within 15 working days with the specific steps taken, and warned that failing to fix the problems may lead to legal action including seizure and injunction (FDA warning letter, January 2026).
FDA's consumer guide says that when a product is unsafe or out of compliance, FDA can ask the company to recall it voluntarily or act to remove a dangerous product from the market.
FDA does not check your supplement before launch, but Amazon checks before and after. As of October 2026, Amazon's dietary supplement policy starts from the same federal rules (21 CFR 101 for labeling and 21 CFR 111 or 117 for manufacturing) and adds proof that FDA itself does not ask for up front. Law firm Epstein Becker Green summarized the change in January 2026: every supplement seller must show third-party cGMP compliance through an Amazon-approved testing provider, and FDA inspections do not count. Amazon's own help pages need a seller login to read, so confirm the current wording in Seller Central.
NutraIngredients reported in December 2025, citing the American Herbal Products Association, that Amazon was rolling the third-party cGMP requirement out to all supplement sellers in phases, with 90 days to start the process after Amazon makes contact. An Amazon recap in Seller Forums mentioned about 30 days of notice instead, so treat the date in your Account Health notification as the deadline that counts. Our guides to Amazon's dietary supplement policy and Amazon supplement testing requirements walk through the full process, the authorized providers and what each step costs.
The practical result: on Amazon, a supplement is checked against FDA's standards by a private lab before it can stay listed, even though FDA never approved it.
For each dietary ingredient, confirm with your manufacturer and supplier whether it was marketed before October 15, 1994 or is otherwise outside the notice requirement. If you cannot document it, talk to a regulatory attorney before you order inventory.
Ask for the facility's FDA registration confirmation and a current accredited third-party cGMP certificate. Amazon will want the certificate anyway. Use our list of questions to ask a supplement manufacturer.
Put in writing who tests what, who releases each batch, who keeps which records and who handles complaints.
Draft the Supplement Facts panel, identity statement and net quantity, and add a domestic address or phone number for adverse event reports. Our Supplement Facts panel guide walks through the panel.
Keep every claim on the structure/function side, keep the proof on file, add the disclaimer, and file the 30-day notice through FDA's online submission portal after you first market the claim.
Decide who answers the phone number or inbox on the label, how a serious event is recognized, and who files the MedWatch report within 15 business days.
When Amazon asks, work with an authorized TIC provider to validate your cGMP certificate and, for higher-risk categories, test the product. Then list with full label images and claims that match the panel.
Proposals to change the system come up often. The one most discussed in 2026 is the Dietary Supplement Listing Act of 2026, S. 3677, introduced by Senator Dick Durbin on January 15, 2026 and referred to the Senate Committee on Health, Education, Labor, and Pensions (bill text, GovInfo). According to trade press coverage, it would require companies to list their products with FDA, including ingredients, an electronic copy of the label and claims, and earlier versions in 2022 and 2024 did not pass.
Two points matter for a brand. First, a listing requirement is not approval: as written, the bill asks for information, not FDA sign-off. Second, it is a bill, not a law. We found no enacted change to the no-premarket-approval rule as of October 2026.
Do it yourself if you sell a familiar formula (common vitamins, minerals or well-known botanicals) made by a registered facility with a current third-party cGMP certificate, and you keep your claims modest. The steps above, plus your manufacturer's paperwork, cover most of the ground.
Talk to a regulatory attorney if you use a novel or synthetic ingredient that may need an NDI notice, sell anything near drug territory such as weight, sleep, blood sugar or hormones, or receive an FDA warning letter or Form 483. Those are legal questions. Evolve does not give legal or regulatory advice and does not run lab tests.
Get marketing and listing help if the rules are handled but the brand is not selling, or your listing, images and label do not line up. That is where we fit. Listing rewrites are $495 per listing through listing optimization, main images, infographics and Premium A+ run $295, $495 or $595 through graphic design, and PPC management starts at $995 a month. Brands that want one person watching all of it pick a brand management plan: Brand Support at 5 hours for $750 a month, Brand Manager at 10 hours for $1,250, Brand Manager Plus at 20 hours for $2,000, or Full Brand Management at 40 hours for $3,600, paid upfront and month to month. Every price is listed on our pricing page.
Want to talk it through first? Email Ian at [email protected] or call or text 719-257-3557. If you only need an attorney, we will tell you that.
FDA: FDA 101, Dietary Supplements
fda.gov · Open source →
FDA: Questions and Answers on Dietary Supplements
fda.gov · Open source →
eCFR: 21 CFR Part 1, Subpart H, Registration of Food Facilities
ecfr.gov · Open source →
FDA: Questions on food facility registration fees and private businesses
fda.gov · Open source →
eCFR: 21 CFR Part 111, Dietary supplement cGMP
ecfr.gov · Open source →
eCFR: 21 CFR 190.6, Requirement for premarket notification
ecfr.gov · Open source →
Cornell LII: 21 U.S.C. 379aa-1, Serious adverse event reporting for dietary supplements
law.cornell.edu · Open source →
FTC: Health Products Compliance Guidance
ftc.gov · Open source →
FDA: Warning letter to a supplement firm, January 9, 2026
fda.gov · Open source →
GovInfo: S. 3677, Dietary Supplement Listing Act of 2026 (introduced)
govinfo.gov · Open source →
Cornell LII: 21 U.S.C. 350l, Mandatory recall authority
law.cornell.edu · Open source →
NutraIngredients: Amazon expands TIC cGMP requirement to all supplement products (Dec 22, 2025)
nutraingredients.com · Open source →
Epstein Becker Green: Amazon's third-party supplement testing mandate explained
ebglaw.com · Open source →
NutraIngredients: Sen. Durbin introduces Dietary Supplement Listing Act of 2026 (Jan 15, 2026)
nutraingredients.com · Open source →


Founder, Evolve Media Agency
Ian has run Evolve Media Agency since 2017 and has sold on Amazon since 2015. He and Megan run brand management, launches, PPC and in-house photo and video for Amazon, Shopify and TikTok Shop brands, including supplement brands, from Colorado. Questions about this page go straight to him at [email protected].
Guide
What Amazon asks for on every supplement listing, and how its verification works.
Checklist
Build or audit your panel line by line under 21 CFR 101.36, with a worked example.
Service
Monthly brand management for supplement brands, from listings to launch.
Free · 30 minutes · No pitch deck
Book a free 30-minute call and bring your label, claims or ASIN. We will show you where FDA's rules and Amazon's rules touch your listing and what to fix first.
Rather email? Write Ian at [email protected]. Call or text 719-257-3557. Watch our YouTube channel, grab the free Ecom Profit Box guides, or join the newsletter.
Tell us what you sell and where you are stuck. Ian replies within one business day, and you get an email right away with a link to book a free 30-minute call.
Rather talk now? Call or text 719-257-3557 or pick a time on Calendly.